These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 24220567

  • 1. PACAP and PAC1 receptor in brain development and behavior.
    Shen S, Gehlert DR, Collier DA.
    Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
    [Abstract] [Full Text] [Related]

  • 2. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J.
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI.
    J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712
    [Abstract] [Full Text] [Related]

  • 7. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
    Hannibal J, Georg B, Fahrenkrug J.
    PLoS One; 2017 Aug 30; 12(11):e0188166. PubMed ID: 29155851
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor.
    Tasma Z, Rees TA, Guo S, Tan S, O'Carroll SJ, Faull RLM, Curtis MA, Christensen SL, Hay DL, Walker CS.
    Br J Pharmacol; 2024 Aug 30; 181(15):2655-2675. PubMed ID: 38616050
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
    Maduna T, Lelievre V.
    J Neurosci Res; 2016 Dec 30; 94(12):1472-1487. PubMed ID: 27717098
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA.
    Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463
    [Abstract] [Full Text] [Related]

  • 13. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

  • 14. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.
    Ekblad E, Jongsma H, Brabet P, Bockaert J, Sundler F.
    Ann N Y Acad Sci; 2000 Oct 02; 921():137-47. PubMed ID: 11193817
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B, Martins RA, Santiago MF, Linden R, Silveira MS.
    Eur J Neurosci; 2010 Aug 02; 32(3):311-21. PubMed ID: 20646049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury.
    Broome ST, Mandwie M, Gorrie CA, Musumeci G, Marzagalli R, Castorina A.
    J Mol Neurosci; 2023 Oct 02; 73(9-10):724-737. PubMed ID: 37646964
    [Abstract] [Full Text] [Related]

  • 18. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun 02; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.